Results 111 to 120 of about 3,342 (167)

Persistent Immune Thrombocytopenia as a Post‐Acute Sequelae of COVID‐19: A Case Report

open access: yesPublic Health Challenges, Volume 5, Issue 4, December 2026.
ABSTRACT Immune thrombocytopenia (ITP) is a recognized hematologic complication associated with coronavirus disease 2019 (COVID‐19), but its persistence years after acute infection remains uncommon. We present a case of a 52‐year‐old male who was diagnosed with COVID‐19 in June 2020. Following recovery from the acute illness, he had persistent fatigue,
Riazullah   +5 more
wiley   +1 more source

The Influence of Type of Maternity Care Provider on Early Breastfeeding Rates. A Retrospective Cohort Study of All Women Who Gave Birth in Victoria, Australia 2010 to 2020

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 6, December 2026.
ABSTRACT Background Breastfeeding plays a vital role in infant health and development. Maternity care providers are well‐positioned to support breastfeeding during the postnatal period. In Australia, there are multiple options for public and private maternity care. To date, there is limited information on how caregiver and hospital type influence early
Maja Johnsson   +6 more
wiley   +1 more source

Swiss Practice Recommendations for Chronic Prurigo Including Prurigo Nodularis

open access: yesInternational Journal of Dermatology, Volume 65, Issue 12, Page 2497-2508, December 2026.
Chronic prurigo, including prurigo nodularis, is a chronic, often treatment‐refractory condition characterized by persistent pruritus and chronic scratch lesions. Advances in the understanding of its underlying pathophysiology have enabled the development of novel targeted therapies; however, management remains challenging due to the expanding range of
Simon M. Mueller   +11 more
wiley   +1 more source

A Confirmatory, Dual Center Nonhuman Primate Study on the Efficacy of Novel Oropharyngeal Spray Immunization With an Adenoviral Vector Vaccine Against RSV—Important Lessons Learned

open access: yesJournal of Medical Primatology, Volume 55, Issue 6, December 2026.
ABSTRACT Background In a randomized, blinded, dual center study across two European primate research facilities, we evaluated the immunogenicity and protective efficacy of a DNA prime—oropharyngeal adenoviral boost vaccination strategy against respiratory syncytial virus (RSV).
Matthias Tenbusch   +15 more
wiley   +1 more source

Improving blood transfusion safety in Somalia beyond infectious disease screening

open access: yes
Vox Sanguinis, EarlyView.
Ayuub Ahmed Osman   +2 more
wiley   +1 more source

Anti‐Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH‐B Study

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Treatment indication for chronic hepatitis B (CHB) varies across clinical guidelines. This study evaluated treatment eligibility and uptake in a large Australian cohort of people with CHB. The REACH‐B study recruited people with CHB managed through a national network of healthcare services.
Behzad Hajarizadeh   +28 more
wiley   +1 more source

New anti HCV drugs in the pipeline

open access: yesRetrovirology, 2010
Bourlière Marc
doaj   +1 more source

Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Eliminating hepatitis C requires focusing efforts on people who inject drugs (PWID). The ARISTOTLE HCV‐HIV program aimed to increase HCV and HIV diagnosis and linkage to care among PWID, particularly those currently injecting and not linked to opioid agonist treatment (OAT).
Sotirios Roussos   +24 more
wiley   +1 more source

Real‐World Effectiveness and Safety of Sofosbuvir‐Based Therapy in Chinese Children and Adolescents With Chronic HCV Infection: A Retrospective Multicentre Study

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
ABSTRACT Few direct‐acting antiviral regimens are approved in China for children and adolescents with chronic hepatitis C virus (HCV) infection and data are limited on their efficacy and safety in this population. This retrospective, multi‐centre study aimed to assess the real‐world effectiveness and safety of ledipasvir/sofosbuvir (LDV/SOF) and ...
Li Liu   +12 more
wiley   +1 more source

The Nucleoside Analogue NITD008, Alone or Combined With Ribavirin, Potently Reduces Hepatitis E Virus Infection in Humanised Mice

open access: yesLiver International, Volume 46, Issue 12, December 2026.
ABSTRACT Background and Aims Hepatitis E virus (HEV) infection is becoming increasingly clinically relevant worldwide, but no approved antiviral therapy currently exists. Ribavirin (RBV) is used off‐label for immunosuppressed patients with chronic hepatitis E, although it is effective in only 80% of patients and linked to side effects.
Annika Volmari   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy